Balyasny Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.6M | Buy |
335,262
+12,751
| +4% | +$1.35M | 0.05% | 342 |
|
2025
Q1 | $40M | Buy |
322,511
+249,636
| +343% | +$31M | 0.07% | 277 |
|
2024
Q4 | $8.97M | Sell |
72,875
-157,457
| -68% | -$19.4M | 0.01% | 702 |
|
2024
Q3 | $25.7M | Sell |
230,332
-14,345
| -6% | -$1.6M | 0.04% | 398 |
|
2024
Q2 | $26.1M | Buy |
244,677
+239,384
| +4,523% | +$25.5M | 0.05% | 390 |
|
2024
Q1 | $637K | Sell |
5,293
-195,160
| -97% | -$23.5M | ﹤0.01% | 1411 |
|
2023
Q4 | $24.7M | Buy |
200,453
+129,531
| +183% | +$15.9M | 0.05% | 386 |
|
2023
Q3 | $9.18M | Sell |
70,922
-42,007
| -37% | -$5.44M | 0.02% | 638 |
|
2023
Q2 | $14M | Buy |
+112,929
| New | +$14M | 0.03% | 516 |
|
2023
Q1 | – | Sell |
-163,382
| Closed | -$26M | – | 2418 |
|
2022
Q4 | $26M | Buy |
+163,382
| New | +$26M | 0.07% | 297 |
|
2022
Q3 | – | Sell |
-79,986
| Closed | -$12.5M | – | 2546 |
|
2022
Q2 | $12.5M | Sell |
79,986
-5,098
| -6% | -$795K | 0.04% | 476 |
|
2022
Q1 | $13.2M | Buy |
+85,084
| New | +$13.2M | 0.04% | 460 |
|
2021
Q3 | – | Sell |
-188,541
| Closed | -$33.5M | – | 1882 |
|
2021
Q2 | $33.5M | Buy |
+188,541
| New | +$33.5M | 0.16% | 143 |
|
2021
Q1 | – | Sell |
-216,291
| Closed | -$35.7M | – | 1735 |
|
2020
Q4 | $35.7M | Buy |
+216,291
| New | +$35.7M | 0.2% | 107 |
|
2019
Q4 | – | Sell |
-190,414
| Closed | -$24.4M | – | 1199 |
|
2019
Q3 | $24.4M | Buy |
190,414
+171,678
| +916% | +$22M | 0.17% | 184 |
|
2019
Q2 | $2.67M | Buy |
18,736
+6,383
| +52% | +$910K | 0.02% | 676 |
|
2019
Q1 | $1.77M | Buy |
+12,353
| New | +$1.77M | 0.01% | 764 |
|
2018
Q4 | – | Sell |
-58,365
| Closed | -$9.81M | – | 1415 |
|
2018
Q3 | $9.81M | Sell |
58,365
-40,451
| -41% | -$6.8M | 0.04% | 411 |
|
2018
Q2 | $17M | Sell |
98,816
-54,291
| -35% | -$9.35M | 0.08% | 303 |
|
2018
Q1 | $23.1M | Sell |
153,107
-112,387
| -42% | -$17M | 0.1% | 261 |
|
2017
Q4 | $35.7M | Buy |
+265,494
| New | +$35.7M | 0.11% | 217 |
|
2017
Q3 | – | Sell |
-270,602
| Closed | -$42.1M | – | 1744 |
|
2017
Q2 | $42.1M | Buy |
270,602
+164,806
| +156% | +$25.6M | 0.17% | 134 |
|
2017
Q1 | $15.4M | Sell |
105,796
-143,901
| -58% | -$20.9M | 0.07% | 313 |
|
2016
Q4 | $27.2M | Sell |
249,697
-139,933
| -36% | -$15.3M | 0.15% | 172 |
|
2016
Q3 | $47.3M | Buy |
389,630
+263,440
| +209% | +$32M | 0.27% | 116 |
|
2016
Q2 | $17.8M | Buy |
126,190
+49,590
| +65% | +$7.01M | 0.12% | 210 |
|
2016
Q1 | $10M | Buy |
+76,600
| New | +$10M | 0.06% | 317 |
|
2015
Q4 | – | Sell |
-7,011
| Closed | -$931K | – | 1184 |
|
2015
Q3 | $931K | Buy |
+7,011
| New | +$931K | 0.01% | 576 |
|
2014
Q3 | – | Sell |
-33,300
| Closed | -$4.9M | – | 553 |
|
2014
Q2 | $4.9M | Buy |
+33,300
| New | +$4.9M | 0.06% | 284 |
|
2013
Q4 | – | Sell |
-156,026
| Closed | -$14.4M | – | 446 |
|
2013
Q3 | $14.4M | Buy |
156,026
+51,874
| +50% | +$4.77M | 0.19% | 118 |
|
2013
Q2 | $7.16M | Buy |
+104,152
| New | +$7.16M | 0.12% | 158 |
|